Showing results (241-250 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|January 9, 2015
A combination of 2D similarity search, pharmacophore, and molecular docking techniques for the identification of vascular endothelial growth factor receptor-2 inhibitorsGuanhua Ai, Caiping Tian, Dawei Deng, et al.Anti-Cancer Drugs|January 9, 2015
Antiangiogenesis as the novel mechanism for justicidin A in the anticancer effect on human bladder cancerYi-Wen Wang, Jing-Jing Chuang, Tsuey-Yu Chang, et al.Anti-Cancer Drugs|January 15, 2015
Combination of SF1126 and gefitinib induces apoptosis of triple-negative breast cancer cells through the PI3K/AKT-mTOR pathwayMiao Deng, Jianguang Wang, Yanbin Chen, et al.Anti-Cancer Drugs|September 24, 2015
Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid: an analysis of 74 patientsYihebali Chi, Shugeng Gao, Feng Du, et al.Anti-Cancer Drugs|August 4, 2015
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulationAndrew J Cowan, Shani L Frayo, Oliver W Press, et al.Anti-Cancer Drugs|October 2, 2015
Comparison of the effectiveness of whole-brain radiotherapy plus temozolomide versus whole-brain radiotherapy in treating brain metastases based on a systematic review of randomized controlled trialsGui-Rong Bai, Jin-Bing An, Yang Chu, et al.Anti-Cancer Drugs|December 26, 2015
Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cellsXinjun Dong, Feiyan Liu, Mianli LiAnti-Cancer Drugs|January 31, 2016
Population pharmacokinetic/pharmacodynamic modeling of tumor growth kinetics in medullary thyroid cancer patients receiving cabozantinibDale R Miles, David R Wada, Nelson L Jumbe, et al.Anti-Cancer Drugs|October 13, 2015
Adjuvant imatinib treatment in gastrointestinal stromal tumor: which risk stratification criteria and for how long? A case reportJean-Yves Blay, Alice LevardAnti-Cancer Drugs|September 17, 2015
Pharmacokinetic study and clinical evaluation of a slow-release 5-fluorouracil implant in pancreatic cancer patientsJing Quan Li, Jing Chun Yang, Jie Xiong Liang, et al.Pageof 464